WESTERN MIDSTREAM ANNOUNCES SECONDARY PUBLIC OFFERING OF COMMON UNITS
Get Alerts OXY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.8%
EPS Growth %: +366.7%
Join SI Premium – FREE
Barclays is acting as the sole book-running manager for the offering. The offering will be made only by means of the prospectus supplement and accompanying base prospectus, which is part of a shelf registration statement that became effective on
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
ABOUT WESTERN MIDSTREAM
Western Midstream Partners, LP ("WES") is a master limited partnership formed to develop, acquire, own, and operate midstream assets. With midstream assets located in
This news release contains forward-looking statements. WES and its general partner believe that their expectations are based on reasonable assumptions. No assurance, however, can be given that such expectations will prove to have been correct. A number of factors could cause actual results to differ materially from the projections, anticipated results or other expectations expressed in this news release, including risks and uncertainties associated with market conditions as they relate to the offering and the Selling Unitholders' ability to close successfully on the offering. See "Risk Factors" in WES's Annual Report on Form 10-K for the year ended December 31, 2023, Quarterly Reports on Form 10-Q for the quarters ended
WESTERN MIDSTREAM CONTACTS
Director, Investor Relations
[email protected]
866-512-3523
Manager, Investor Relations
[email protected]
866-512-3523
View original content to download multimedia:https://www.prnewswire.com/news-releases/western-midstream-announces-secondary-public-offering-of-common-units-302220320.html
SOURCE Western Midstream Partners, LP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cosmos Health signs letter of intent to acquire Doc Pharma for $24M
- SEC proposes eliminating Order Protection Rule for trading
- Adial Pharmaceuticals acquires Azora Therapeutics for up to $64 million
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Barclays, Crude Oil, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share